About GVB Biopharma
GVB Biopharma is a company based in United States founded in 2016 by Jack Feldman and Phillip Swindells was acquired by 22nd Century in May 2022. GVB Biopharma has raised $13.56 million across 6 funding rounds from investors including 22nd Century. GVB Biopharma offers products and services including CBD Isolate and White Label Products.
- Headquarter United States
- Founders Jack Feldman, Phillip Swindells
- SectorsConsumer
- Website gvbbiopharma.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by 22nd Century (May 2022)
- Legal Name Gvb Biopharma
- Total Equity Funding$13.56M (USD)
in 6 rounds
- Latest Funding Round$1M (USD), Series A
May 2022
- Investors
- Acquired by22nd Century
(May 2022)
Products & Services of GVB Biopharma
GVB Biopharma offers a comprehensive portfolio of products and services, including CBD Isolate and White Label Products.
CBD isolate is produced and supplied as a hemp-based raw material for various applications.
White label products are provided for ingestibles and topicals, allowing customization for wholesale and retail use.
Apps and channels of GVB Biopharma
its YouTube channel GVB Biopharma has 70 subscribers and 20 videos.
Videos from GVB Biopharma
The most watched videos on GVB Biopharma's YouTube channel, GVB Biopharma (70 subscribers). Click a video to play it here.
More on GVB Biopharma.
Funding Insights of GVB Biopharma
GVB Biopharma has successfully raised a total of $13.56M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.56M
- Total Rounds 6
- Last Round Series A — $1M
- First Round $450,000
(Apr 2020)
All 6 funding rounds of GVB Biopharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $1M | Series A | – | – | – |
| Jan 2022 | $1.75M | Series A | – | – | – |
| Nov 2021 | $1.5M | Series A | – | – | – |
| Nov 2020 | $7.61M | Series A | – | – | – |
| May 2020 | $1.25M | Seed | – | – | – |
| Apr 2020 | $450,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in GVB Biopharma
GVB Biopharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 22nd Century.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of nicotine products | 1998 | xxiicentury.com | Williamsville, United States |
Investor details for GVB Biopharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GVB Biopharma
20 people are tracked at GVB Biopharma (14 in leadership, 1 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Jack Feldman | Co-Founder & President | Leadership |
Phillip Swindells | Co-Founder & CEO | Leadership |
Hugh Kinsman | CFO | Leadership |
Izzy Maggay | VP, Engineering | Leadership |
Keith Manley | VP, Sales | Leadership |
Gabi de la Guardia | Executive Chief of Staff | Leadership |
Sunny Garcia | VP, Project Management | Leadership |
Bharath Pogula | Director, Research & Development, GVB Oregon | Leadership |
Drew Spiegel | COO | Leadership |
Brandon Johnson | Sales Director | Leadership |
Sam Meitus | Director Of Inside Sales | Leadership |
Karl Muldowney | Commercial Director Europe & UK | Leadership |
Lyndon Jones | Director Of Facilities | Leadership |
David Lombera | Director Of Accounting | Leadership |
Theodore Swindells | Principal & Chairman | Board & advisors |
Sebastian Ravitz | Advisor | Team |
Joaquin Salas | Senior Accountant | Team |
Sona S. | Shipping Logistics | Team |
Joe Cousino | Business Development Coordinator | Team |
Shawna Pettigrew | Accounts Receivable Manager | Team |
Complete people profiles for GVB Biopharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GVB Biopharma
4 dated milestones of GVB Biopharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded GVB Biopharma is founded.
- Funding First funding round of $450K.
- Exit Acquired by 22nd Century.
- Funding Latest funding round, Series A, of $1.0M.
Web traffic of GVB Biopharma
The website of GVB Biopharma (gvbbiopharma.com) receives about 22.5K visits a month.
- Monthly visits22.5K
▲ 90.3% vs previous month
Websites whose visitors overlap most with GVB Biopharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gencanna.com | 100% | – | – | View details | |
laurelcrest.com | laurelcrest.com | 86% | – | #7,732,180 | – |
jm-wholesale.co.uk | jm-wholesale.co.uk | 85% | – | #616,324 | – |
| nabis.com | 83% | 84.6K | #327,057 | View details | |
| hemplivingwholesale.com | 78% | – | #1,341,705 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for GVB Biopharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to GVB Biopharma
10 companies that operate in the same segment as GVB Biopharma (Cannabis Platforms & Ecosystem Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Legal medical and recreational cannabis products are manufactured. | 2016 | Ann Arbor, Michigan, United States | USD 89.95 M | – | 214 | |
Cannabis is cultivated, processed, and retailed by PharmaCann vertically. | 2014 | Oak Park, Illinois, United States | USD 218.7 M | – | 979 | |
Consumer lawn and garden products and services are provided. | 1868 | Columbus, Ohio, United States | – | USD 3.41 B | 5,300 | |
Provider of cannabis dispensaries, cultivators, CPG brands, and services | – | Denver, Colorado, United States | – | USD 172.45 M | – | |
Provider of cannabis based medical and consumer products | 2016 | New York, New York, United States | USD 13.78 M | USD 17.42 M | – | |
Offers medical & wellness cannabis products sourcing and processing services | 2021 | London, England, United Kingdom | USD 5.32 M | USD 258.08 K | 168 | |
Cannabis products are produced, cultivated, branded, and processed. | 2017 | New York, New York, United States | – | – | 2,198 | |
Developer of water-soluble cannabinoid extraction technologies | 2018 | Los Alamos, New Mexico, United States | USD 47.59 M | – | – | |
Medicinal cannabis is produced by Blueberries Medical in Colombia. | 2013 | Bogota, Bogota, Colombia | – | USD 228.08 K | – | |
Enzymatic bioconversions are designed for cannabinoid product synthesis. | 2014 | Monrovia, California, United States | – | – | 16 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GVB Biopharma
GVB Biopharma was founded in 2016 and raised its 1st funding round 4 years after it was founded.
GVB Biopharma is headquartered in United States.
Phillip Swindells is the current CEO of GVB Biopharma. They have also founded this company.
GVB Biopharma is a funded company, having raised a total of $13.56M across 6 funding rounds to date. The company's 1st funding round was a Seed of $450K, raised on Apr 2020.
GVB Biopharma was established in 2016 in the United States, with operations centered on the cannabis sector. Cannabis extracts are manufactured and supplied, alongside white label solutions for product development. Services encompass extraction processes and formulation support for biopharma applications. Leadership is provided by co-founders Jack Feldman as President and Phillip Swindells as CEO, ensuring focus on regulatory-compliant production within the domestic market.
GVB Biopharma offers CBD Isolate and White Label Products.
GVB Biopharma has 1 investor. Key investors include 22nd Century.
GVB Biopharma operates through Gvb Biopharma.
Yes. GVB Biopharma was acquired by 22nd Century in May 2022.